A detailed history of Frazier Financial Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 223 shares of MRNA stock, worth $10,443. This represents 0.01% of its overall portfolio holdings.

Number of Shares
223
Previous 223 -0.0%
Holding current value
$10,443
Previous $26.5 Million 43.72%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$85.37 - $115.44 $256 - $346
3 Added 1.36%
223 $23.8 Million
Q4 2023

Feb 09, 2024

BUY
$69.51 - $104.43 $15,292 - $22,974
220 New
220 $21.9 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $18.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.